GO:0016072 rRNA metabolic process | Genes & Methods

Ribosomal RNA (rRNA) is the most abundant RNA in cells and forms the structural and catalytic scaffold of the ribosome, the molecular machine that synthesizes all proteins. The Gene Ontology term GO:0016072, rRNA metabolic process, encompasses the chemical reactions and pathways involving rRNA, including its synthesis, processing, modification, assembly into ribosomal subunits, and turnover. Because ribosome production consumes a large fraction of cellular energy and is tightly coupled to growth, rRNA metabolism sits at the interface of transcription, RNA processing, and translation control. Researchers study this process to understand how cells adjust protein synthesis capacity during development, stress, and disease. Recent work has expanded the view of rRNA metabolism beyond a housekeeping pathway. Epitranscriptomic rRNA fingerprinting has revealed tissue-of-origin and tumor-specific signatures, indicating that rRNA modifications are dynamically regulated and can serve as biomarkers. The integrated stress response regulates 18S nonfunctional rRNA decay in mammals, linking rRNA quality control to translational reprogramming under stress. In addition, RECQ5 has been shown to mediate pre-rRNA processing in the nucleolus, highlighting the role of helicases in ribosome biogenesis. These findings make GO:0016072 a high-value target for mechanistic and translational research. For biomedical researchers, rRNA metabolic process is relevant to cancer biology, ribosomopathies, and metabolic diseases. METTL5-mediated 18S rRNA m6A modification promotes oncogenic mRNA translation and intrahepatic cholangiocarcinoma progression, directly connecting a single rRNA modification to tumorigenesis. Methyltransferase-like proteins are emerging as therapeutic targets in cancer, and rRNA methylation is a well-known determinant of antibiotic resistance. Thus, understanding GO:0016072 provides a framework for interrogating ribosome biogenesis as a druggable and diagnostic axis.

GO:0016072 rRNA metabolic process is defined as the chemical reactions and pathways involving rRNA, ribosomal RNA, a structural constituent of ribosomes. In practice, this term covers the full life cycle of rRNA molecules: transcription of ribosomal DNA, cleavage and trimming of precursor rRNA, site-specific chemical modifications such as methylation and pseudouridylation, assembly with ribosomal proteins into pre-ribosomal particles, nuclear export, and quality-control decay of defective or nonfunctional rRNA. It is a biological process term, meaning it describes a series of molecular events rather than a single molecular function or cellular location.

rRNA metabolic process is fundamental because ribosomes are the sole machines for protein synthesis, and rRNA constitutes the catalytic core of the ribosome. Any perturbation in rRNA synthesis, processing, or modification alters the translational output of the cell, affecting growth, proliferation, differentiation, and stress responses. In disease, aberrant rRNA metabolism contributes to oncogenic translation, as shown for METTL5-mediated 18S rRNA m6A modification in intrahepatic cholangiocarcinoma, and to ribosome-related pathologies. Moreover, rRNA methylation is a clinically relevant mechanism of antibiotic resistance in bacteria. Studying GO:0016072 therefore informs cancer biology, antimicrobial drug development, and our understanding of translational control.

The following genes and proteins are experimentally implicated in rRNA metabolic process, based on the verified literature.

rRNA metabolic process is regulated at multiple levels. Feedback regulation of ribosome assembly coordinates rRNA synthesis and processing with ribosomal protein availability, preventing wasteful overproduction. The integrated stress response regulates 18S nonfunctional rRNA decay in mammals, linking rRNA quality control to cellular stress signaling. Epitranscriptomic modifications, such as METTL5-mediated 18S rRNA m6A, add a reversible regulatory layer that influences translation and disease progression. In bacteria, rRNA methylation is a regulated resistance mechanism against antibiotics. Together, these layers ensure that rRNA metabolism adapts to growth, stress, and environmental challenges.

Cancer cells often exhibit elevated ribosome biogenesis to support rapid proliferation. METTL5-mediated 18S rRNA m6A modification promotes oncogenic mRNA translation and intrahepatic cholangiocarcinoma progression, directly linking an rRNA modification enzyme to tumorigenesis. Epitranscriptomic rRNA fingerprinting reveals tumor-specific signatures, suggesting that rRNA modification patterns could serve as cancer biomarkers. Methyltransferase-like proteins, including rRNA methyltransferases, are being explored as therapeutic targets in cancer.

Defects in rRNA processing or assembly can cause ribosomopathies, a group of disorders characterized by impaired ribosome production. The integrated stress response regulates 18S nonfunctional rRNA decay, and its dysregulation may contribute to stress-related pathologies. RECQ5-mediated pre-rRNA processing is important for nucleolar function, and its disruption could affect ribosome biogenesis and genome stability.

In bacteria, rRNA methylation is a major mechanism of resistance to antibiotics that target the ribosome. Understanding rRNA metabolic enzymes in pathogens can inform the design of new antimicrobials that overcome resistance.

Gut microbiota and metabolomics have been linked to liver regeneration in fatty liver disease, a context where altered cellular metabolism may intersect with ribosome biogenesis. Although direct evidence for rRNA metabolic process in this condition is limited, the broader relevance of translational control in liver disease is emerging.

Ribo-seq measures translated mRNA fragments and can reveal how changes in rRNA metabolism affect global translation efficiency. It is used to test whether rRNA modifications or processing defects alter the translational landscape.

RNA-seq and specialized epitranscriptomic methods detect rRNA processing intermediates and modification patterns. Epitranscriptomic rRNA fingerprinting has been used to identify tissue-of-origin and tumor-specific signatures.

Mass spectrometry-based proteomics identifies ribosomal proteins and assembly factors associated with pre-rRNA particles. Interactomics can map the protein network around rRNA metabolic enzymes such as METTL5 and RECQ5.

Fluorescence microscopy and nucleolar markers visualize pre-rRNA processing compartments and assembly dynamics. These assays are used to assess nucleolar stress and localization of rRNA processing factors.

Researchers studying rRNA metabolic process-related genes often need to determine whether a candidate gene is causally involved in ribosome biogenesis, translation control, or disease progression. CRISPR-based models provide the precision required to test these hypotheses in relevant cell types.

GO:0016072 rRNA metabolic process is a central biological process that governs the production, modification, assembly, and quality control of ribosomal RNA. Its dysregulation is implicated in cancer, ribosomopathies, stress responses, and antibiotic resistance, making it a rich area for mechanistic and translational research. Advances in epitranscriptomic profiling and CRISPR modeling continue to reveal new layers of regulation and disease relevance. Understanding rRNA metabolism provides a foundation for developing diagnostics and therapeutics targeting ribosome biogenesis.